Salbutamol Sulfate EP Impurity K (HCl Salt)
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

Salbutamol Sulfate EP Impurity K (HCl Salt)

● 재고 있음

카탈로그 번호:VE0025659
CAS 번호:N/A
분자식:C13H19Cl2NO3
분자량:308.20 g/mol

에 대한 추가 정보

모약물

Salbutamol

IUPAC명

2-(tert-butylamino)-1-(3-chloro-4-hydroxy-5-(hydroxymethyl)phenyl)ethanone hydrochloride

동의어

N/A

SMILES

OCC1=C(O)C(Cl)=CC(C(CNC(C)(C)C)=O)=C1.Cl

InChI

InChI=1S/C13H18ClNO3.ClH/c1-13(2,3)15-6-11(17)8-4-9(7-16)12(18)10(14)5-8;/h4-5,15-16,18H,6-7H2,1-3H3;1H

설명

Salbutamol Sulfate EP Impurity K (HCl Salt) is a process-related degradation product observed in salbutamol sulfate manufacture and stability studies, requiring targeted analytical control to meet pharmacopoeial limits. Physicochemical characterization typically includes LC-MS, HPLC with validated impurity methods, and NMR to confirm structure and salt form. Its presence can indicate incomplete salt formation, oxidative or hydrolytic pathways, or side reactions during synthesis, affecting batch purity and impurity profiling. Risk-based control strategies involve qualification, validated cleaning, impurity-specific reference standards and validated limits aligned with ICH Q3A and Q3B expectations to ensure consistent pharmaceutical quality.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url